FDA Approved: GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR — Supplemental Application (Xeris Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR, a glucagon injection solution, expanding its device format for treating severe h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Drugs mentioned

• GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (GLUCAGON INJECTION, SOLUTION)

Snippet

SUPPL AP for GVOKE HYPOPEN 0.5 MG AUTO-INJECTOR (GLUCAGON INJECTION, SOLUTION)